9/26
02:11 pm
acst
Acasti Pharma Inc. (NASDAQ: ACST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Report
Acasti Pharma Inc. (NASDAQ: ACST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
9/26
12:11 pm
acst
Rating for ACST
Medium
Report
Rating for ACST
9/26
12:11 pm
acst
Rating for ACST
Medium
Report
Rating for ACST